EUVIMEDEUVIMED entdecken
Crossref

Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer

Yusuke Seiki, Kenji Ikezawa, Ko Watsuji, Makiko Urabe, Yugo Kai, Ryoji Takada, Takuo Yamai, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Miki Ishibashi, Kazuyoshi Ohkawa

International Journal of Clinical Oncology · 2024

DOI: 10.1007/s10147-024-02544-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Yusuke Seiki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Dietary Supplements, Zinc, Dysgeusia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although patients with advanced pancreatic cancer (PC) often experience dysgeusia with zinc deficiency during chemotherapy, data on zinc supplementation for dysgeusia and its effects on nutritional status are scarce. We aimed to examine the efficacy of zinc supplementation in patients with advanced PC. METHODS: Thirty-three patients with unresectable PC who presented with dysgeusia and zinc deficiency during chemotherapy and received zinc acetate hydrate between January 2018 and December 2022 were included. We evaluated the changes in serum zinc levels and the improvement in dysgeusia. Among the 26 patients who received zinc supplementation for 12 weeks, we also compared patient characteristics and changes in serum zinc and albumin levels between patients who showed improvement in dysgeusia (effective group) and those who did not (non-effective group). RESULTS: The serum zinc level increased significantly after zinc supplementation (median: 60 µg/dL at baseline, 99.5 µg/dL at 4 weeks, 101 µg/dL at 8 weeks and 101 µg/dL at 12 weeks). The rate of improvement in dysgeusia increased over time (18.2% at 4 weeks, 33.3% at 8 weeks, and 42.4% at 12 weeks). Comparing the effective group and non-effective group revealed that while the median serum albumin level of the effective group did not change, the non-effective group showed a significant decrease from baseline to 12 weeks (3.2 g/dL to 3.0 g/dL, p = 0.03). CONCLUSION: Zinc supplementation significantly increased serum zinc levels, improving dysgeusia. Zinc supplementation might also contribute to maintaining nutritional status in patients with unresectable PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsDietary SupplementsZincDysgeusiaHumansMaleFemaleAgedMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsNutritional StatusAged, 80 and overRetrospective Studies

Stichwörter der Autor:innen

AlbuminNutritional indicatorOral careTaste disorderZinc deficiency

Substanzen

Zinc

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
  • Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan. ikezawa-ke@oici.jp.
  • Department of Dentistry, Osaka International Cancer Institute, Osaka, Japan.

Zitieren

APA

Seiki, Y., Ikezawa, K., Watsuji, K., Urabe, M., Kai, Y., Takada, R., Yamai, T., Mukai, K., Nakabori, T., Uehara, H., Ishibashi, M., & Ohkawa, K. (2024). Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02544-w

Vancouver

Seiki Y, Ikezawa K, Watsuji K, Urabe M, Kai Y, Takada R, et al. Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02544-w

BibTeX
@article{Seiki2024,
  author = {Seiki, Yusuke and Ikezawa, Kenji and Watsuji, Ko and Urabe, Makiko and Kai, Yugo and Takada, Ryoji and Yamai, Takuo and Mukai, Kaori and Nakabori, Tasuku and Uehara, Hiroyuki and Ishibashi, Miki and Ohkawa, Kazuyoshi},
  title = {Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1007/s10147-024-02544-w}
}
Kostenlos starten →